AI platform matches cancer patients to clinical trials, therapies
The technology, developed by life-sciences software firm Deep Lens, integrates cancer genetic data into an advanced platform to connect patients with studies and treatments.
The technology, developed by life-sciences software firm Deep Lens, integrates cancer genetic data into an advanced platform to connect patients with studies and treatments.
Produced by clinical trial software firm Florence Healthcare, the awards program seeks to recognize the contribution research professionals make to the industry.
The oncology drug development firm has announced 27% abscopal response in soft-tissue lesions with use of Veyonda and low-dose radiotherapy.